Regarding the point of discussion as to whether the most recent assay expands the inferred asset or simply confirms the inferred asset, it's important to realise that right now the task of the moment is not further inference, but rather a move towards decisive confirmation. That BTR have had stunning strikes is not in question. But whenever there are big strikes, there persists for a short while at the start the lingering thought "Is this the real deal?". S36-036 smashes home the answer emphatically. This assay confirms the world-class asset and UPRATES both the grade and size of it. If S36-036 had been the first drill of the phase 5 program, everyone would be going ga-ga over it. It just so happens that in the context of the killer hits BTR has been landing lately, 300m at 1.8% is just another day at the Kitumba office...
BTR Price at posting:
$1.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)